ANKS1A: A Potential Drug Target and Biomarker (G23294)
ANKS1A: A Potential Drug Target and Biomarker
ANKS1A, or ANK302, is a protein that was discovered in 2007 and is located in the annelid gene family. The annelid gene family is a group of non-coding RNAs that have been characterized for their ability to create small interfering RNA (siRNA) in a variety of organisms, including the roundworm Caenorhabditis elegans. ANKS1A is a member of the annelid gene family and has been shown to have similar properties to other members of the family, such as the ability to create siRNA and the capacity to interact with DNA-binding proteins.
One of the unique features of ANKS1A is its ability to create a specific type of siRNA, known as a sterile alpha motif (SAM) RNA. SAM RNAs are a type of siRNA that have been shown to play important roles in regulating gene expression in a variety of organisms, including humans. They are typically composed of 20-22 nucleotides and are able to bind specifically to a specific target mRNA. This ability to create SAM RNAs makes ANKS1A a potentially interesting drug target, as drugs that target specific mRNAs could be useful in treating a variety of diseases.
In addition to its ability to create SAM RNAs, ANKS1A has also been shown to interact with a variety of transcription factors and other proteins that are involved in gene expression. This suggests that ANKS1A may be involved in the regulation of gene expression and could potentially be a useful target for drugs that are designed to modulate gene function.
The discovery of ANKS1A and its potential as a drug target has sparked a great deal of interest and research in the field of RNA biology and gene regulation. While more research is needed to fully understand the properties and functions of ANKS1A, its unique ability to create SAM RNAs and interact with other proteins suggests that it could be a valuable tool for the development of new drugs and therapies.
Protein Name: Ankyrin Repeat And Sterile Alpha Motif Domain Containing 1A
Functions: Regulator of different signaling pathways. Regulates EPHA8 receptor tyrosine kinase signaling to control cell migration and neurite retraction (By similarity)
The "ANKS1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKS1A comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ANKS1B | ANKS3 | ANKS4B | ANKS6 | ANKUB1 | ANKZF1 | ANLN | Annexin | ANO1 | ANO10 | ANO2 | ANO3 | ANO4 | ANO5 | ANO6 | ANO7 | ANO7L1 | ANO8 | ANO9 | Anoctamin | ANOS1 | ANOS2P | ANP32A | ANP32A-IT1 | ANP32AP1 | ANP32B | ANP32C | ANP32D | ANP32E | ANPEP | ANTKMT | ANTXR1 | ANTXR2 | ANTXRL | ANTXRLP1 | ANXA1 | ANXA10 | ANXA11 | ANXA13 | ANXA2 | ANXA2P1 | ANXA2P2 | ANXA2P3 | ANXA2R | ANXA2R-AS1 | ANXA2R-OT1 | ANXA3 | ANXA4 | ANXA5 | ANXA6 | ANXA7 | ANXA8 | ANXA8L1 | ANXA8L2 | ANXA9 | AOAH | AOC1 | AOC2 | AOC3 | AOC4P | AOPEP | AOX1 | AOX2P | AP-1 Transcription Factor Complex | AP1AR | AP1B1 | AP1B1P1 | AP1G1 | AP1G2 | AP1M1 | AP1M2 | AP1S1 | AP1S2 | AP1S3 | AP2A1 | AP2A2 | AP2B1 | AP2M1 | AP2S1 | AP3B1 | AP3B2 | AP3D1 | AP3M1 | AP3M2 | AP3S1 | AP3S2 | AP4B1 | AP4B1-AS1 | AP4E1 | AP4M1 | AP4S1 | AP5B1 | AP5M1 | AP5S1 | AP5Z1 | APAF1 | APBA1 | APBA2 | APBA3 | APBB1
